Medical progress, UAB - financials and debts

Company age: 22 y. 9 mo.

Update

Medical progress - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 103,488 179,775 376,242 389,283 839,794 1,262,308 1,081,302 856,105
Profit before tax 10,374 33,610 91,786 151,054 230,242 - 306,322 99,519
Net profit 10,287 33,414 87,665 151,054 224,936 216,742 260,200 79,770
Equity 15,555 48,968 113,105 169,159 234,435 451,177 328,952 258,722
Liabilities 95,838 163,238 167,423 178,442 225,900 355,739 240,837 186,843
Non-current assets 27,502 22,787 20,531 55,713 90,425 169,283 91,988 72,360
Current assets 82,233 187,983 259,397 290,529 367,740 634,821 475,887 371,560
Total assets 109,735 210,770 279,928 346,242 458,165 804,104 567,875 443,920
Taxes paid
STI taxes - - - - - - 154,006 158,461
Social insurance contributions - - - - - 28,547 50,946 61,974
Financial indicators
Revenue change y/y +2306.7% +73.7% +109.3% +3.5% +115.7% +50.3% -14.3% -20.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 9.4% 15.9% 31.3% 43.6% 49.1% 27.0% 45.8% 18.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 66.1% 68.2% 77.5% 89.3% 95.9% 48.0% 79.1% 30.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 9.9% 18.6% 23.3% 38.8% 26.8% 17.2% 24.1% 9.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 10.0% 18.7% 24.4% 38.8% 27.4% - 28.3% 11.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 6.2 3.3 1.5 1.1 1.0 0.8 0.7 0.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 28,224 44,027 94,061 80,542 148,198 111,380 88,270 60,431

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medical progress - Social security debts

From To Debt, €
2026-07-19 2026-07-19 2875.44
2026-07-16 2026-07-17 2875.44
2026-03-27 2026-03-27 5655.06
2026-03-17 2026-03-18 5655.06
2025-07-16 2025-07-16 2011.45
2025-05-07 2025-05-14 5.12
2025-02-18 2025-02-18 12.22
2025-01-22 2025-02-16 13.49
2025-01-20 2025-01-21 7.70
2025-01-16 2025-01-19 3803.00
2025-01-02 2025-01-15 7.70
2024-12-22 2024-12-31 7.70
2024-12-17 2024-12-20 62.80
2024-12-10 2024-12-16 7.70
2024-10-18 2024-11-21 15.53
2024-07-16 2024-07-17 84.38
2024-05-16 2024-07-14 84.38
2024-04-16 2024-05-14 84.38
2024-02-05 2024-02-14 6.32
2024-01-24 2024-01-28 144.19
2024-01-23 2024-01-23 168.46
2024-01-16 2024-01-22 163.76
2024-01-15 2024-01-15 9.34
2023-12-18 2024-01-11 9.34
2023-11-16 2023-11-20 143.80
2023-10-17 2023-10-17 3510.78
2023-09-18 2023-09-18 3023.30
2023-05-02 2023-05-11 0.41
2023-04-26 2023-04-28 0.41
2023-03-16 2023-03-16 1003.41
2022-11-29 2022-12-06 4.27
2022-07-18 2022-07-19 710.38
2022-06-16 2022-06-30 568.34
2022-03-16 2022-03-16 161.34
2022-02-17 2022-02-28 0.27
2022-01-31 2022-02-13 0.27
2021-11-05 2022-01-30 0.08

Medical progress - VMI tax arrears

From To Overdue, €
2026-05-30 2026-06-02 14.49
2026-05-28 2026-05-29 10.74
2026-05-01 2026-05-25 9.74
2026-04-30 2026-04-30 5.55
2026-04-01 2026-04-28 0.59
2026-03-18 2026-03-18 4524.54
2026-02-21 2026-02-21 3344.19
2026-02-16 2026-02-20 2934.55
2026-01-29 2026-02-15 44.55
2026-01-15 2026-01-28 0.56
2026-01-14 2026-01-14 0.26
2026-01-08 2026-01-13 0.56
2026-01-01 2026-01-07 32.48
2025-12-31 2025-12-31 32.2
2025-12-01 2025-12-05 13.84
2025-11-02 2025-11-09 17.22
2025-10-16 2025-10-21 3171.52
2025-10-02 2025-10-15 1.2
2025-09-28 2025-09-29 1196.31
2025-09-26 2025-09-27 40.31
2025-08-23 2025-08-25 12.13
2025-08-21 2025-08-22 201.2
2025-08-19 2025-08-20 483.56
2025-08-08 2025-08-18 264.72
2025-08-07 2025-08-07 3.84
2025-08-05 2025-08-06 15203.84
2025-07-30 2025-08-04 3.84
2025-07-28 2025-07-29 3554.18
2025-06-28 2025-06-28 1935.85
2025-02-27 2025-02-27 11.9
2025-02-25 2025-02-26 11.69
2025-02-22 2025-02-24 12.5
2025-02-20 2025-02-21 462.02
2025-02-19 2025-02-19 452.87
2025-02-18 2025-02-18 1191.58
2025-02-17 2025-02-17 4302.0
2025-02-15 2025-02-16 485.99
2025-01-30 2025-02-14 0.86
2025-01-23 2025-01-29 103.74
2025-01-22 2025-01-22 101.37
2024-12-30 2025-01-21 1.8
2024-12-24 2024-12-27 1.79
2024-12-20 2024-12-20 6728.99
2024-12-19 2024-12-19 6745.54
2024-11-28 2024-12-18 0.54
2024-11-17 2024-11-23 2634.82
2024-10-16 2024-10-16 9577.79
2024-10-10 2024-10-15 9409.33
2024-10-01 2024-10-09 10.33

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medical progress, UAB (code 126422910) is a Private Limited Liability Company engaged in the retail sale of other medical and orthopaedic goods. In 2025, the latest financial year, the company generated revenue of €856.1K and net profit of €79.8K, with a profit margin of 9.3%. Performance weakened from 2024, when revenue was €1.08M and net profit reached €260.2K, after €1.26M of revenue and €216.7K of net profit in 2023. This shows a two-year decline in turnover, with revenue down 20.8% year on year in 2025 and 32.2% below the 2023 level. The balance sheet also contracted, as total assets fell to €443.9K from €567.9K in 2024 and €804.1K in 2023. Equity stood at €258.7K and liabilities at €186.8K in 2025, with an equity ratio of 58.3% and debt-to-equity of 0.72. Asset turnover was 1.93x. Based on staff data, revenue per employee was €61.1K and profit per employee was €5.7K.